iifl-logo

Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Nifty Pharma ETF

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Exchange Traded Funds (ETFs)

Launch Date

21-Jun-2021

Fund Manager

Jitendra Tolani

Net Assets (Rs. cr)

942.04

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Nifty Pharma ETF - Nav Details

Nav Date

:  14-Aug-2025

NAV [Rs.]

:  22.701

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

Nippon India Nifty Pharma ETF- NAV Chart

Nippon India Nifty Pharma ETF- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
2.18
-0.97
3.54
6.81
1.11
20.44
-
11.69
Category Avg
0.23
-1.85
2.69
9.67
4.4
15.92
20.46
13.44
Category Best
3.26
7.6
18.91
43.8
70.54
42.46
38.37
341.2
Category Worst
-2.05
-9.76
-7.14
-14.85
-14.08
-32.48
5.41
-25.55

Nippon India Nifty Pharma ETF- Latest Dividends

No Records Found

Nippon India Nifty Pharma ETF- Investment Details

Min. Investment(Rs.)

1000

Increm.Investment(Rs.)

0

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology22.481240870211.77
EquityCiplaPharmaceuticals & Biotechnology10.68647327100.63
EquityDivi's Lab.Pharmaceuticals & Biotechnology10.2314612296.37
EquityDr Reddy's LabsPharmaceuticals & Biotechnology9.4570072589.01
EquityLupinPharmaceuticals & Biotechnology5.7027825653.67
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.7812037245.04
EquityLaurus LabsPharmaceuticals & Biotechnology4.1845038139.37
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology3.9317329336.98
EquityAurobindo PharmaPharmaceuticals & Biotechnology3.8932181936.68
EquityMankind PharmaPharmaceuticals & Biotechnology3.5412999933.37
EquityAlkem LabPharmaceuticals & Biotechnology3.316192531.15
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.9628739227.87
EquityBioconPharmaceuticals & Biotechnology2.8769120427.05
EquityIpca Labs.Pharmaceuticals & Biotechnology2.5015993123.57
EquityAbbott IndiaPharmaceuticals & Biotechnology2.19600820.67
EquityGland PharmaPharmaceuticals & Biotechnology2.019158418.91
EquityJ B Chemicals &Pharmaceuticals & Biotechnology1.759324416.49
EquityAjanta PharmaPharmaceuticals & Biotechnology1.414844313.32
EquityNatco PharmaPharmaceuticals & Biotechnology1.041031149.83
EquityGranules IndiaPharmaceuticals & Biotechnology0.841668927.92
Cash & Cash Equivalent
Net CA & OthersNet CA & Others-/-0.2302.04
Reverse RepoTREPS-/-0.0300.23
Cash & Cash EquivalentC C I-/-0.0000.00

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.